Literature DB >> 19269802

Tyrosine phosphorylation: thirty years and counting.

Tony Hunter1.   

Abstract

In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging. Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a number of which have been approved for clinical use. The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269802      PMCID: PMC2670436          DOI: 10.1016/j.ceb.2009.01.028

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  48 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Treatment for chronic myelogenous leukemia: the long road to imatinib.

Authors:  Tony Hunter
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 4.  Tyrosine phosphorylation: an emerging regulatory device of bacterial physiology.

Authors:  Christophe Grangeasse; Alain J Cozzone; Josef Deutscher; Ivan Mijakovic
Journal:  Trends Biochem Sci       Date:  2007-01-08       Impact factor: 13.807

5.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

6.  Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.

Authors:  Jayne M Stommel; Alec C Kimmelman; Haoqiang Ying; Roustem Nabioullin; Aditya H Ponugoti; Ruprecht Wiedemeyer; Alexander H Stegh; James E Bradner; Keith L Ligon; Cameron Brennan; Lynda Chin; Ronald A DePinho
Journal:  Science       Date:  2007-09-13       Impact factor: 47.728

7.  Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.

Authors:  Ultan McDermott; Sreenath V Sharma; Lori Dowell; Patricia Greninger; Clara Montagut; Jennifer Lamb; Heidi Archibald; Raul Raudales; Angela Tam; Diana Lee; S Michael Rothenberg; Jeffrey G Supko; Raffaella Sordella; Lindsey E Ulkus; A John Iafrate; Shyamala Maheswaran; Ching Ni Njauw; Hensin Tsao; Lisa Drew; Jeff H Hanke; Xiao-Jun Ma; Mark G Erlander; Nathanael S Gray; Daniel A Haber; Jeffrey Settleman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

8.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

9.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

10.  Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.

Authors:  Xuewu Zhang; Kerry A Pickin; Ron Bose; Natalia Jura; Philip A Cole; John Kuriyan
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

View more
  267 in total

1.  Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Authors:  Svenja Beckmann; Steffen Hahnel; Katia Cailliau; Mathieu Vanderstraete; Edith Browaeys; Colette Dissous; Christoph G Grevelding
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 2.  A peek into the complex realm of histone phosphorylation.

Authors:  Taraswi Banerjee; Debabrata Chakravarti
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

3.  Multiple post-translational modifications affect heterologous protein synthesis.

Authors:  Alexander A Tokmakov; Atsushi Kurotani; Tetsuo Takagi; Mitsutoshi Toyama; Mikako Shirouzu; Yasuo Fukami; Shigeyuki Yokoyama
Journal:  J Biol Chem       Date:  2012-06-06       Impact factor: 5.157

4.  Mosaic aging.

Authors:  Lary C Walker; James G Herndon
Journal:  Med Hypotheses       Date:  2010-01-27       Impact factor: 1.538

Review 5.  The LAT story: a tale of cooperativity, coordination, and choreography.

Authors:  Lakshmi Balagopalan; Nathan P Coussens; Eilon Sherman; Lawrence E Samelson; Connie L Sommers
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-07       Impact factor: 10.005

6.  Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.

Authors:  Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

7.  Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Authors:  Guangchang Zhou; Faraz Khan; Qing Dai; Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Biosyst       Date:  2012-07-06

8.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

9.  PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.

Authors:  Yanlin Yu; Meng Dai; Andrew Lu; Ellen Yu; Glenn Merlino
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

10.  Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma.

Authors:  Jie Xu; Li-Fan Zeng; Weihua Shen; John J Turchi; Zhong-Yin Zhang
Journal:  Biochem Biophys Res Commun       Date:  2013-09-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.